SHRENIK VYAS: Open Payments
NPI 1689244709 · LINCOLN, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,309 in 114 payments from 24 companies in 2025. Trend: 2023 $2,549 · 2024 $3,393 · 2025 $3,309
Food & beverage: $3,309
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 18 | $666 |
| Amgen Inc. | 13 | $477 |
| ABBVIE INC. | 17 | $363 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $192 |
| Lilly USA, LLC | 9 | $179 |
| Exact Sciences Corporation | 7 | $144 |
| Novo Nordisk Inc | 6 | $142 |
| PFIZER INC. | 4 | $141 |
| Actelion Pharmaceuticals US, Inc. | 1 | $125 |
| Inspire Medical Systems, Inc. | 6 | $125 |
Products named: JARDIANCE, EVENITY, AIRSUPRA, VRAYLAR, FARXIGA, UPTRAVI, INSPIRE, INGREZZA.
Industry payments across RI — which companies pay providers there.
